瑞康医药
(002589)
| 流通市值：44.79亿 | | | 总市值：49.35亿 |
| 流通股本：13.66亿 | | | 总股本：15.05亿 |
| 报告期 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 4,687,872,464.68 | 4,041,303,476.86 | 4,022,756,394.67 | 5,060,786,524.48 |
| 应收票据及应收账款 | 4,508,658,717.31 | 4,512,271,131.18 | 4,173,882,614.65 | 3,980,031,274.02 |
| 其中：应收票据 | 531,013,386.57 | 600,578,280.79 | 223,149,758.91 | 217,042,949.57 |
| 应收账款 | 3,977,645,330.74 | 3,911,692,850.39 | 3,950,732,855.74 | 3,762,988,324.45 |
| 应收款项融资 | 191,043,589.83 | 151,632,715.8 | 130,828,024.54 | 242,008,979.47 |
| 预付款项 | 225,522,116.88 | 201,036,763.15 | 156,326,480.44 | 97,371,027.52 |
| 其他应收款合计 | 1,015,016,213.97 | 927,408,488.43 | 968,760,114.62 | 990,014,899.01 |
| 存货 | 892,320,235.92 | 926,475,160.27 | 978,041,450.83 | 1,119,070,006.89 |
| 其他流动资产 | 46,393,068.46 | 46,758,152.61 | 53,463,698.1 | 49,809,999.14 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 11,566,826,407.05 | 10,806,885,888.3 | 10,484,058,777.85 | 11,539,092,710.53 |
| 非流动资产: | | | | |
| 长期股权投资 | 532,028,367.29 | 534,359,554.44 | 671,807,419.45 | 655,387,619.45 |
| 其他权益工具投资 | 5,217,561 | 5,217,561 | 5,217,561 | 5,217,561 |
| 其他非流动金融资产 | 191,423,577.02 | 191,423,577.02 | 191,423,577.02 | 191,423,577.02 |
| 投资性房地产 | 598,308,523.67 | 595,609,834.6 | 600,441,662.16 | 605,263,430.46 |
| 固定资产 | 1,906,823,361.04 | 1,955,991,746.78 | 1,821,830,436.23 | 1,845,564,712 |
| 在建工程 | 299,901,363.38 | 279,675,619.92 | 420,812,103.38 | 429,339,745.13 |
| 生产性生物资产 | - | - | 0 | - |
| 油气资产 | - | - | 0 | - |
| 使用权资产 | 5,275,658.48 | 5,734,841.79 | 6,541,717.33 | 2,520,026.49 |
| 无形资产 | 492,607,894.39 | 516,578,375.12 | 531,285,432.6 | 552,391,028.45 |
| 开发支出 | - | - | - | 0 |
| 商誉 | 146,667,621.5 | 146,667,621.5 | 146,667,621.5 | 146,667,621.5 |
| 长期待摊费用 | 41,444,433.53 | 45,982,064.05 | 50,032,699.86 | 60,866,161.19 |
| 递延所得税资产 | 287,253,806.44 | 283,710,934.45 | 243,375,931.04 | 284,444,301.64 |
| 其他非流动资产 | 345,071,458.84 | 357,431,017.72 | 385,444,841.43 | 391,127,536.62 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 4,852,023,626.58 | 4,918,382,748.39 | 5,074,881,003 | 5,170,213,320.95 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 16,418,850,033.63 | 15,725,268,636.69 | 15,558,939,780.85 | 16,709,306,031.48 |
| 流动负债: | | | | |
| 短期借款 | 6,514,273,651.99 | 5,530,410,983 | 4,802,284,312.2 | 6,556,061,480.41 |
| 应付票据及应付账款 | 3,256,020,567.59 | 3,675,812,448.56 | 4,234,585,093.18 | 3,722,628,491.71 |
| 其中：应付票据 | 733,842,321.72 | 1,016,948,673.15 | 1,506,961,411.23 | 448,598,750.69 |
| 应付账款 | 2,522,178,245.87 | 2,658,863,775.41 | 2,727,623,681.95 | 3,274,029,741.02 |
| 预收款项 | - | - | 0 | 0 |
| 合同负债 | 24,947,179 | 27,305,660.33 | 17,541,023.29 | 29,116,668.24 |
| 应付职工薪酬 | 18,688,655.75 | 18,100,718.63 | 17,868,520.75 | 17,907,481.2 |
| 应交税费 | 24,742,490.5 | 19,773,575.97 | 16,174,318.78 | 14,782,301.91 |
| 其他应付款合计 | 273,399,248.13 | 278,415,717.78 | 368,693,249.12 | 316,910,045.46 |
| 其中:应付利息 | - | - | - | 0 |
| 应付股利 | 3,943,415.4 | 3,943,415.4 | 3,943,415.4 | 3,943,415.4 |
| 一年内到期的非流动负债 | 2,952,771.84 | 3,052,771.84 | 8,994,616.22 | 6,123,925.88 |
| 其他流动负债 | 42,078,926.27 | 99,711,925.35 | 115,730,887.97 | 97,587,210.56 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 10,157,103,491.07 | 9,652,583,801.46 | 9,581,872,021.51 | 10,761,117,605.37 |
| 非流动负债: | | | | |
| 长期借款 | 502,257,003.28 | 326,852,499.49 | 269,500,000 | 261,273,967.64 |
| 租赁负债 | 4,274,771.58 | 4,544,658.24 | 4,642,625.89 | 835,714.42 |
| 递延收益 | 4,841,789.63 | 1,550,506.12 | 1,585,850.03 | 1,619,323.09 |
| 递延所得税负债 | 45,102,441.55 | 46,163,671.26 | 45,791,190.53 | 47,482,426.87 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 556,476,006.04 | 379,111,335.11 | 321,519,666.45 | 311,211,432.02 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 10,713,579,497.11 | 10,031,695,136.57 | 9,903,391,687.96 | 11,072,329,037.39 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 1,504,710,471 | 1,504,710,471 | 1,504,710,471 | 1,504,710,471 |
| 资本公积 | 3,585,998,351.49 | 3,585,998,351.49 | 3,719,909,185.63 | 3,719,909,185.63 |
| 减:库存股 | 57,653,208.08 | 57,653,208.08 | 230,651,529.31 | 230,651,529.31 |
| 盈余公积 | 159,527,095.27 | 159,527,095.27 | 159,527,095.27 | 159,527,095.27 |
| 未分配利润 | 313,543,568.52 | 305,762,579.67 | 309,467,463.74 | 294,298,491.05 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 5,506,126,278.2 | 5,498,345,289.35 | 5,462,962,686.33 | 5,447,793,713.64 |
| 少数股东权益 | 199,144,258.32 | 195,228,210.77 | 192,585,406.56 | 189,183,280.45 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 5,705,270,536.52 | 5,693,573,500.12 | 5,655,548,092.89 | 5,636,976,994.09 |
| 负债和股东权益合计 | 16,418,850,033.63 | 15,725,268,636.69 | 15,558,939,780.85 | 16,709,306,031.48 |
| 公告日期 | 2024-10-31 | 2024-08-27 | 2024-04-30 | 2024-04-30 |
| 审计意见(境内) | | | | 标准无保留意见 |